5IJ4

Solution structure of AN1-type zinc finger domain from Cuz1 (Cdc48 associated ubiquitin-like/zinc-finger protein-1)

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D 1H-15N NOESY	1.0 mM [U-100% 15N] cuz1, 5 mM Tris, 50 mM NaCl, 0.2 mM ZnCl2, 1 mM DTT	90% H2O/10% D2O	50 mM	7.5	1 atm	25	Agilent DD2 600
2	3D 1H-13C NOESY	0.7 mM [U-100% 13C; U-100% 15N] cuz1, 5 mM Tris, 50 mM NaCl, 0.2 mM ZnCl2, 1 mM DTT	90% H2O/10% D2O	50 mM	7.5	1 atm	25	Agilent DD2 600
3	3D HNCA	0.7 mM [U-100% 13C; U-100% 15N] cuz1, 5 mM Tris, 50 mM NaCl, 0.2 mM ZnCl2, 1 mM DTT	90% H2O/10% D2O	50 mM	7.5	1 atm	25	Agilent DD2 600
4	3D HN(CO)CA	0.7 mM [U-100% 13C; U-100% 15N] cuz1, 5 mM Tris, 50 mM NaCl, 0.2 mM ZnCl2, 1 mM DTT	90% H2O/10% D2O	50 mM	7.5	1 atm	25	Agilent DD2 600
5	3D HNCO	0.7 mM [U-100% 13C; U-100% 15N] cuz1, 5 mM Tris, 50 mM NaCl, 0.2 mM ZnCl2, 1 mM DTT	90% H2O/10% D2O	50 mM	7.5	1 atm	25	Agilent DD2 600
6	3D HN(CA)CO	0.7 mM [U-100% 13C; U-100% 15N] cuz1, 5 mM Tris, 50 mM NaCl, 0.2 mM ZnCl2, 1 mM DTT	90% H2O/10% D2O	50 mM	7.5	1 atm	25	Agilent DD2 600
7	3D HNCACB	0.7 mM [U-100% 13C; U-100% 15N] cuz1, 5 mM Tris, 50 mM NaCl, 0.2 mM ZnCl2, 1 mM DTT	90% H2O/10% D2O	50 mM	7.5	1 atm	25	Agilent DD2 600
8	3D HN(COCA)CB	0.7 mM [U-100% 13C; U-100% 15N] cuz1, 5 mM Tris, 50 mM NaCl, 0.2 mM ZnCl2, 1 mM DTT	90% H2O/10% D2O	50 mM	7.5	1 atm	25	Agilent DD2 600
9	3D C(CO)NH	0.7 mM [U-100% 13C; U-100% 15N] cuz1, 5 mM Tris, 50 mM NaCl, 0.2 mM ZnCl2, 1 mM DTT	90% H2O/10% D2O	50 mM	7.5	1 atm	25	Agilent DD2 600
10	3D H(CCO)NH	0.7 mM [U-100% 13C; U-100% 15N] cuz1, 5 mM Tris, 50 mM NaCl, 0.2 mM ZnCl2, 1 mM DTT	90% H2O/10% D2O	50 mM	7.5	1 atm	25	Agilent DD2 600
11	3D HCCH-TOCSY	0.7 mM [U-100% 13C; U-100% 15N] cuz1, 5 mM Tris, 50 mM NaCl, 0.2 mM ZnCl2, 1 mM DTT	90% H2O/10% D2O	50 mM	7.5	1 atm	25	Agilent DD2 600
12	2D NOESY	0.85 mM cuz1, 5 mM [U-2H] Tris, 50 mM NaCl, 0.2 mM ZnCl2, 1 mM [U-2H] DTT	100% D2O	50 mM	7.5	1 atm	25	Bruker AVANCE III 750
13	2D TOCSY	0.85 mM cuz1, 5 mM [U-2H] Tris, 50 mM NaCl, 0.2 mM ZnCl2, 1 mM [U-2H] DTT	100% D2O	50 mM	7.5	1 atm	25	Bruker AVANCE III 750
14	2D 1H-15N HSQC	0.7 mM [U-100% 13C; U-100% 15N] cuz1, 5 mM Tris, 50 mM NaCl, 0.2 mM ZnCl2, 1 mM DTT	90% H2O/10% D2O	50 mM	7.5	1 atm	25	Agilent DD2 600
15	2D 1H-13C HSQC	0.7 mM [U-100% 13C; U-100% 15N] cuz1, 5 mM Tris, 50 mM NaCl, 0.2 mM ZnCl2, 1 mM DTT	90% H2O/10% D2O	50 mM	7.5	1 atm	25	Agilent DD2 600
16	2D 1H-13C HSQC aromatic	0.7 mM [U-100% 13C; U-100% 15N] cuz1, 5 mM Tris, 50 mM NaCl, 0.2 mM ZnCl2, 1 mM DTT	90% H2O/10% D2O	50 mM	7.5	1 atm	25	Agilent DD2 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Agilent	DD2	600
2	Bruker	AVANCE III	750

NMR Refinement
Method	Details	Software
simulated annealing	simulated annealing with torsion angle dynamics	CYANA

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	15
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure calculation	CYANA		Guntert, Mumenthaler and Wuthrich
2	chemical shift assignment	CARA		Keller and Wuthrich
3	peak picking	CARA		Keller and Wuthrich
4	processing	hmsIST		Hyberts, S.G and Wagner, G
5	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
6	refinement	CYANA		Guntert, Mumenthaler and Wuthrich

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.